Ulrich Duehrsen

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt et al. · Journal of Clinical Oncology · 2012 · 826 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

Hartmut Goldschmidt, H M Lokhorst, E K et al. · Leukemia · 2017 · 201 citations · Full text

Medicine, Hematology, Oncology +14

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Christoph Scheid, P. Sonneveld, Ingo Schmidt‐Wolf et al. · Haematologica · 2013 · 127 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Acquired immunodeficiency syndrome‐related lymphoma

Paris S. Mitrou, Keikawus Arastéh, Dirk Schuermann et al. · Cancer · 2006 · 89 citations

Medicine, Immunology, Oncology +16

Prolonged survival with improved tolerability in higher‐risk myelodysplastic syndromes: azacitidine compared with low dose ara‐C

Pierre Fenaux, Norbert Gattermann, John F. Seymour et al. · British Journal of Haematology · 2010 · 74 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17